Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience (Q34801580)

4 August 2017

1 reference

title

Extracorporeal liver perfusion as hepatic assist in acute liver failure: a review of world experience (English)

1 reference

4 August 2017

1 reference

Peter Neuhaus

1 reference

4 August 2017

Andreas Pascher

1 reference

4 August 2017

Igor M Sauer

series ordinal

1 reference

4 August 2017

Claus Hammer

series ordinal

1 reference

4 August 2017

Joerg C Gerlach

series ordinal

1 reference

4 August 2017

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

309-324

1 reference

Relation of Alpha-Fetoprotein in Acute Hepatitis to Severity and Prognosis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Multivariate analysis of prognostic factors in fulminant hepatitis B.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Early indicators of prognosis in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Heterologous liver perfusion in treatment of hepatic failure.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Mechanisms of resistance to injury in pig livers perfused with blood from patients in liver failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Extracorporeal liver perfusion for hepatic coma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Hepatic coma due to fulminating hepatitis treated with extracorporeal pig-liver perfusion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Heterologous extracorporeal hepatic support: haemodynamic, biochemical, and immunological observations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Long-term hepatic support by intermittent multi-species liver perfusions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Acute Hepatic Coma Successfully Treated by Extracorporeal Baboon Liver Perfusions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Clinical Experience of Postoperative Hepatic Failure Treatment with Pig or Baboon Liver Cross-Hemodialysis with an Interposed Membrane

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Heterologous liver perfusion in acute hepatic failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Heterologous bovine liver perfusion therapy of acute hepatic failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Extracorporeal perfusion of pig liver in the treatment of acute liver failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Extracorporeal liver perfusion system for successful hepatic support pending liver regeneration or liver transplantation: a pre-clinical controlled trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Immunological studies in patients receiving repeated allogeneic anc xenogeneic liver hemoperfusions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Pig-liver perfusion. Extracorporeal pig-liver perfusion in a patient with acute hepatic failure.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Extracorporeal assistance to the liver

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Haemorrhage as a Complication of Extracorporeal Pig Liver Perfusion: Studies on Mechanism and Prevention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Extracorporeal perfusion for the treatment of acute liver failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

East meets West: acute liver failure in the global village

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Acute hepatic failure: a Western perspective

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Acute hepatic failure in India: a perspective from the East

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Will artificial liver therapy ever become a reality? Historical aspects and future prospects of the artificial liver

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Controlled trial of exchange-transfusion therapy in fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

An extracorporeal device for hepatic coma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Postdilution hemofiltration in the management of acute hepatic failure: a pilot study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Treatment of Hepatic Coma by Exchange Blood Transfusion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Acute hepatic necrosis with stupor or coma. An analysis of thirty-one patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Plasmapheresis with Albumin as Main Substitute in Acute Hepatic Coma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Charcoal haemoperfusion in the treatment of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Clinical experience with charcoal and resin hemoperfusion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Earlier charcoal haemoperfusion in fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

The Hepatix extracorporeal liver assist device: initial clinical experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

Immunopathological observations after xenogeneic liver perfusions using donor pigs transgenic for human decay-accelerating factor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3089.2002.01076.X

7 January 2021

10.1034/J.1399-3089.2002.01076.X

Identifiers

DOI

1 reference

4 August 2017

1 reference